Iron Overload, Oxidative Stress, and Somatic Mutations in MDS: What Is the Association?

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• Iron overload (IOL) is common in myelodysplastic syndromes (MDS), often due to red blood cell production and transfusions.
• Somatic mutations (SM) are prevalent in MDS and are crucial for risk stratification.
• Current MDS treatments that reduce transfusion dependence are limited.

Purpose of the Study:

• To review how IOL and oxidative stress interact with specific SM in MDS.
• To understand the influence of these interactions on cellular physiology.
• To identify potential therapeutic targets for MDS.

Main Methods:

• Literature review using PubMed searches.
• Keywords included specific mutations, iron, oxidative stress, and reactive oxygen species (ROS).
• Focused on studies related to hematopoietic stem/progenitor cells, bone marrow microenvironment, MDS, and other myeloid disorders.

Main Results:

• Approximately 31 SM and four familial conditions were investigated.
• Analysis included SM frequency, gain/loss of function, early/late mutation status, and gene function.
• The interplay between mutations, iron, and oxidative stress was examined.

Conclusions:

• Limited MDS therapies necessitate exploring IOL and ROS interactions with SM.
• These interactions influence hematopoietic system physiology, potentially driving bone marrow failure or malignant transformation.
• Optimizing strategies to reduce IOL or neutralize ROS may benefit MDS patients.